Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 35 filings·Updated 28 Sept 2026
Showing 10 of 35 filings.
28 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Shentracon Chemicals Ltd – Closure of Trading Window from 01st October, 2026 till the expiry of 48 hours from the declaration of the Unaudited Financial Results for the quarter and half year ended 30th September, 2026.

Shentracon Chemicals Ltd – Closure of Trading Window from 01st October, 2026 till the expiry of 48 hours from the declaration of the Unaudited Financial Results for the quarter and half year ended 30th September, 2026.

Filed 16:02View Source
22 Sept 20261 filing
Corp. ActionRecord Date

Record date fixed for 1:2 equity share sub-division following AGM approval

Record date and sub-division details

  • Record date fixed for equity sub-division on 26 October 2026.
  • Sub-division ratio 1:2 (Rs10 to Rs5), fully paid-up, pari passu, approved at AGM.
  • AGM approval attained on 21 August 2026.
Filed 17:21View Source
31 Aug 20261 filing
Company UpdateChange of Name

Shentracon Chemicals Limited changes name to Midaas Fashions Limited; CIN updated, effective 29 August 2026

Name change details

  • Former name: Shentracon Chemicals Limited; new name: Midaas Fashions Limited.
  • Effective date of name change: 29 August 2026.
  • Regulatory approvals: MCA issued fresh Certificate of Incorporation; ROC registered object clause alteration.
  • CIN change: old CIN L24299WB1993PLC059449 to new CIN L32111WB1993PLC059449.
  • Object Clause alteration registered with ROC on 31 August 2026.
  • Impact on stakeholders: rights and liabilities unaffected; two-year display obligation for old and new names.
  • Status: approvals completed; no further approvals indicated.
Filed 19:41View Source
21 Aug 20262 filings
AGM/EGMAGM

Shentracon Chemicals AGM held via VC/OAVM on 21 August 2026; all resolutions passed.

AGM details

  • AGM held on 21 August 2026 at 1:10 PM IST via VC/OAVM.

Resolutions

  • Resolution 1: Ordinary—adopt audited standalone financial statements for year ended March 2026.
  • Resolution 2: Ordinary—appoint director by rotation and reappoint if eligible.
  • Resolution 3: Ordinary—appoint Hanissh Kanakraj Jain as director.
  • Resolution 4: Ordinary—appoint Amit Lalit Jain as director.
  • Resolution 5: Special—change designation of Amit Lalit Jain to Managing Director.
  • Resolution 6: Special—appoint Ashish Bakliwal as non-executive independent director.
  • Resolution 7: Special—appoint Madhuri Toshniwal as non-executive independent director.
  • Resolution 8: Special—change the name of the company.
  • Resolution 9: Special—shift registered office to Maharashtra from West Bengal.
  • Resolution 10: Special—alter object clause and MOA as per Companies Act, 2013.
  • Resolution 11: Ordinary—sub-division of equity shares.
  • Resolution 12: Ordinary—reclassification of preference share capital.
  • Resolution 13: Special—approvals for loans, investments and guarantees under section 186.
  • Resolution 14: Special—approvals for loans or guarantees under section 185.

Voting results

  • All resolutions passed unanimously with 100% in favour; no against or invalid.

Dividend

  • No dividend declared or announced at this AGM.

Director changes

  • Amit Lalit Jain designation changed to Managing Director.
  • Independent Directors appointed: Ashish Bakliwal and Madhuri Toshniwal.

Auditors

  • No auditor changes disclosed in this filing.

Material related party transactions

  • No material related party transactions disclosed.

Other material approvals

  • Loans/investments/guarantees approvals under sections 186 and 185; MOA/object clause alterations.
Filed 19:19View Source
AGM/EGMAGM

Shentracon Chemicals hosts 33rd AGM via VC/OAVM with MD designation change and multiple corporate actions

AGM Details

  • AGM held on 21 August 2026 at 01:10 PM IST via VC/OAVM.

Ordinary Business

  • Adopt audited standalone financial statements for the financial year ended 31 March 2026.
  • Re-appointment of director retiring by rotation: Hanissh Kanakraj Jaain.

Special Business

  • Appointment of Hanissh Kanakraj Jaain as Director.
  • Appointment of Amit Lalit Jain as Director.
  • Change in designation: Amit Lalit Jain from Director to MD.
  • Appointment of Ashish Bakliwal as Non-Executive Independent Director.
  • Appointment of Madhuri Toshniwal as Non-Executive Independent Director.
  • Change the Company name.
  • Shift registered office from West Bengal to Maharashtra.
  • Alter Object Clause and adopt MOA under the Companies Act 2013.
  • Sub-division of equity shares.
  • Reclassification of preference share capital.
  • Approval for loans, investments, guarantees and providing securities under Section 186.
  • Approval for granting loans, guaranteeing or providing securities under Section 185.

Voting Status

  • Voting results to be declared within the prescribed timeline.
Filed 19:07View Source
13 Aug 20261 filing
Company UpdateNewspaper Publication

The Stock Exchange and stakeholders are requested to take on record, Newspaper publication made with respect to the Unaudited Financial Result for the quarter ended 30th June, 2026.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 16:25View Source
12 Aug 20261 filing
Board MeetingOutcome of Board Meeting

Shentracon Chemicals approves unaudited standalone results for quarter ended 30 June 2026; limited review report issued

Financial results approved

  • Unaudited standalone results for quarter ended 30 June 2026 approved.
  • Limited Review Report by Mark & Co. enclosed; conclusion not modified.

Other disclosures

  • Company has no subsidiary/associate/joint venture; segment reporting not applicable.
  • Board meeting held on 12 August 2026; results approved in meeting.

Audit status

  • Limited Review concluded with no material misstatement; auditor's conclusion not modified.

Regulatory/compliance

  • No material regulatory or legal matters disclosed.
Filed 16:23View Source
7 Aug 20261 filing
Board Meeting

Shentracon Chemicals to hold board meeting on Aug 12, 2026 to consider unaudited Q1 results

Meeting Details

  • Board meeting scheduled for 12 August 2026; time and venue not disclosed.

Key Agenda Items

  • To consider and approve unaudited financial results for quarter ended 30 June 2026.

Other Notes

  • Trading window closed from July 1, 2026; reopens 48 hours after results are announced.
Filed 13:14View Source
30 Jul 20261 filing
Company UpdateNewspaper Publication

The Stock Exchange and stakeholders are requested to take on record , Intimation with respect to the newspaper publication.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 14:01View Source
29 Jul 20261 filing
Company UpdateNewspaper Publication

The Stock Exchange and Stakeholders are requested to take on record , Intimation pertaining to the Pre Newspaper publication made with respect to the Annual General Meeting of the Company.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 13:20View Source
Showing 10 of 35 filings